ArticleOpen forum infectious diseases2021
Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 Isolates.
Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- A two-variant model of SARS-COV-2 transmission: estimating the characteristics of a newly emerging strain.BMC infectious diseases · 2024Article
- Challenges in Emerging Vaccines and Future Promising Candidates against SARS-CoV-2 Variants.Journal of immunology research · 2024Review
- Multiplexed RT-qPCR Coupled with Whole-Genome Sequencing to Monitor a SARS-CoV-2 Omicron Variant of Concern in a Hospital Laboratory Setting in Latvia.Diagnostics (Basel, Switzerland) · 2023Article
- Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays.Diagnostic microbiology and infectious disease · 2022Article
- Article
- Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes.Signal transduction and targeted therapy · 2022Article
- Review
- Severe Acute Respiratory Syndrome Type 2-Causing Coronavirus: Variants and Preventive Strategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Review
- Two Years of Evolutionary Dynamics of SARS-CoV-2 in Mexico, With Emphasis on the Variants of Concern.Frontiers in microbiology · 2022Article
- Article
- Jumping a Moving Train: SARS-CoV-2 Evolution in Real Time.Journal of the Pediatric Infectious Diseases Society · 2021Review
- Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021.Journal of clinical microbiology · 2021Article
- SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021.medRxiv : the preprint server for health sciences · 2021Article
- Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies.Scientific reports · 2021Article
- Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes.bioRxiv : the preprint server for biology · 2021Article
- Emerging SARS-CoV-2 Diversity Revealed by Rapid Whole-Genome Sequence Typing.Genome biology and evolution · 2021Article
- Immune transcriptomes from hospitalized patients infected with the SARS-CoV-2 variants B.1.1.7 and B.1.1.7 carrying the E484K escape mutation.medRxiv : the preprint server for health sciences · 2021Article
- SARS-CoV-2 Variants Associated with Vaccine Breakthrough in the Delaware Valley through Summer 2021.mBio · 2021Article
- Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia.PloS one · 2021Article
Corrections and comments
- Update of
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the genome of a B.1.1.7+E484K severe acute respiratory syndrome coronavirus 2 from Southeastern Pennsylvania and compare it with all high-coverage B.1.1.7+E484K genomes (n = 235) available. Analyses showed the existence of at least 4 distinct clades of this variant circulating in the United States and the possibility of at least 59 independent acquisitions of the E484K mutation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.